Skip to Content Skip to Content

Coronavirus

Debate: Should we waive COVID-19 vaccine patents for low-income countries?

Debate: Should we waive COVID-19 vaccine patents for low-income countries?

Harsha Thirumurthy of the Perelman School of Medicine argued that we should waive COVID-19 vaccine patents for low-income countries. “We simply can’t bring an end to the pandemic—here in the U.S. or elsewhere—without rapidly closing the global vaccine gap,” he wrote. “And we can’t close that gap without waivers of patent protections that are keeping lower-income countries from manufacturing vaccines themselves.”

With more kids eligible for vaccines, is the pandemic in a new phase?
Child wearing mask in school writes at a desk

With more kids eligible for vaccines, is the pandemic in a new phase?

With the FDA authorization last week, 28 million more children are eligible to be vaccinated against COVID-19. Experts from the School of Nursing and Perelman School of Medicine share their thoughts about what to expect in the weeks and months to come.

Katherine Unger Baillie

The controversy surrounding vaccinations, then and now
Person in a white coat reaching into a refrigerator full of bagged vaccines.

Image: Dan Burke

The controversy surrounding vaccinations, then and now

Robert Aronowitz, Walter H. and Leonore C. Annenberg Professor in the Social Sciences, reflects on vaccine hesitancy today compared to the past, and the politicization of public health.

From Omnia

COVID now a ‘major cause of death’ in kids but many parents remain hesitant on vaccine

COVID now a ‘major cause of death’ in kids but many parents remain hesitant on vaccine

Researchers co-led by Kathleen Hall Jamieson of the Annenberg Public Policy Center found that full FDA approval will help convince parents to get their children vaccinated against COVID-19. “As more evidence of children getting vaccinated appears, people will feel more comfortable,” Jamieson said.

Do COVID-19 vaccine incentives work?

Do COVID-19 vaccine incentives work?

Kevin Volpp of the Perelman School of Medicine said he is interested to know how this year’s vaccine-incentive programs will impact COVID-19 booster rates now. “People might learn that if you wait you’ll get an incentive next time,” he said.